Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa

Hepatology

Volumn 27, Issue 4, 1998, Pages 1149-1156

  Zeuzem, Stefan ^a,d   Lee, Jung Hun ^a   Franke, Alexa ^a   Rüster, Brigitte ^b   Prümmer, Otto ^c   Herrmann, Günter ^a   Roth, W Kurt ^b  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON ANTIBODY; RECOMBINANT ALPHA2A INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIREMIA;

ADULT; AGED; ANTIBODIES; CHRONIC DISEASE; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; RNA, VIRAL;

EID: 0031924165     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270433     Document Type: Article

References (19)

1. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JR Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. HEPATOLOGY 1996;24:778-789.
2. Van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-1479.
3. Pagliaro L, Craxi A, Cammaá C, Tiné F, Di Marco V, Lo Iacono O, Almasio P. Interferon-α for chronic hepatitis C: an analysis of pretreatment clinical predictors of response. HEPATOLOGY 1994;19:820-828.
4. Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon X Casarin P, Belussi F, et al. Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. HEPATOLOGY 1995;22:700706.
5. Pawlotsky J-M, Roudot-Thoraval F, Bastie A, Darthuy F, Rémiré J, Métreau J-M, Zafrani E-S, et al. Factors affecting treatment responses to interferon-α in chronic hepatitis C. J Infect Dis 1996;174:l-7.
6. Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, Schiff ER, Bacon BR. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-1109.
7. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 1996;334:77-81.
8. Moribe T, Hayashi N, Kanazawa Y, Mita E, Fusamoto H, Negi M, Kaneshige T, et al. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy. Gastroenterology 1995;108:789-795.
9. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: relationship to genotypes of hepatitis C virus. HEPATOLOGY 1992;16:293-299.
10. Tsubota A, Chayama K, Ikeda K, Yasuji A, Koida I, Saitoh S, Hashimoto M, et al. Factors predictive of response to interferon- therapy in hepatitis C virus infection. HEPATOLOGY 1994;19:1088-1094.
11. Nousbaum J-B, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C, Collaborative Study Group. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161-168.
12. Magrin S, Craxi A, Fabiano C, Marino L, Fiorentino G, Lo Iacono O, Volpes R, et al. HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (Southern Italy). J Hepatol 1996;25:583-590.
13. Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, Mizokami M, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341:1501-1504.
14. Booth JCL, Foster GR, Kumar U, Galassini R, Goldin RD, Brown JL, Thomas HC. Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferonα. Gut 1995;36:427-432.
15. Zeuzem S, Schmidt JM, Lee J-H, Rüster B, Roth WK. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. HEPATOLOGY 1996;23:366-371.
16. Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, et al. Loss of serum HCV RNA at week 4 of interferon-α therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J Med Virol 1995;46:109-115.
17. Hino K, Okuda M, Konishi T, Ishiko H, Okita K. Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy. Dig Dis Sci 1995;40:14-20.
18. Karino Y, Toyota J, Sugawara M, Higashino K, Sato T, Ohmura T, Suga T, et al. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C. Am J Gastroenterol 1997;92:61-65.
19. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. HEPATOLOGY 1994;19:1513-1520.